Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c16e4731f86a0b2112005b662042f215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78700e3d689cd9fd0c9e86f78c63d732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61822800f3c32bf29229964c62760eac http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_450206054dc21e18341e8e91a9783f14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6747263f43c142527c0435881784056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fae0202b744929d86f658a8a5161707 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_051bd9cb3d9e398da0de5c1f8d37a333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd7328a7fc794213d7eddd764104b01c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 |
filingDate |
2010-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2d70d60ff22133e4195dba790ade1ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2c20f3e64dffa7c916171f681716299 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_830c9537ff6e5a6262fe2e3b0da63d5a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d293888466e3b292a89fc00b27a0373 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_715c3a7363823578a3f3f53dde28d010 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d8cf46249c5c70e14be51260a13b355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb77366e1ff2eb7dadf5bdee0dddb5aa |
publicationDate |
2010-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2010116196-A2 |
titleOfInvention |
Diagnosisof and treatment gluten-induced autoimmune diseases |
abstract |
The invention relates to selective diagnosis of gluten-induced autoimmune diseases by binding assays utilizing the main celiac epitope present on proteins of the transglutaminase family. The invention also relates to treatment of gluten-induced autoimmune diseases by inhibiting binding of celiac autoantibodies by therapeutic compounds. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2855530-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10961319-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3521315-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2855530-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10005846-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11718686-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013045469-A1 |
priorityDate |
2009-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |